157 results
8-K
ynxdvtz 44bfd7q
14 Nov 23
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
12:00am
8-K
9tza8
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
EX-1.1
3hzzujab135t9 qpe
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.1
wjf5vg7w
30 Sep 22
Other Events
8:00am
8-K
EX-99.1
isc10n
21 Sep 22
Alaunos Therapeutics Highlights Data from TCR-T Library Phase 1/2 Trial at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference
8:41am
8-K
EX-99.1
9jbd0xu5 qq
6 Sep 22
Alaunos Therapeutics Announces Early Clinical Data Showing Objective Clinical Response Using its TCR-T Cell Therapy
8:21am